ANDERMAN TODD (Chief Legal Officer) sold 7.9% of their position (11.98K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $87.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/13/2026ACC: 0001104659-26-115551
Officer· Chief Legal Officer
Since Oct 2024
-11.98K
Net shares
Net seller
$87.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
11.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−11.98K
Price / share
$7.29
Trade value
$87.36K
% of position
7.9%
10/8/2026
152.47K→140.48K
Total
Net shares
−11.98K
Net value
-$87.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/8/2026 | S · Sale | −11.98K | $7.29 | $87.36K | 7.9% | 152.47K | 140.48K |
| Total | −11.98K | -$87.36K | ||||||
Derivative Transactions0
No derivative transactions reported